PharmaSphere

Drug discovery and biotech · by Receptor.AI

AI drug design platform with dedicated sub-platforms for Small Molecules, Peptides, and Proximity Inducers, combining 40+ experimentally validated AI methodologies for molecular docking, target validation, and drug selectivity enhancement.

Where it ranks

Current edition · updated Oct 20, 2026

What it does

AI drug design platform with dedicated sub-platforms for Small Molecules, Peptides, and Proximity Inducers, combining 40+ experimentally validated AI methodologies for molecular docking, target validation, and drug selectivity enhancement.

  • structure-based virtual screening
  • ADME-Tox safety assessment
  • multi-target polypharmacology profiling
  • drug candidate optimization
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
pharma drug discovery teams
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Receptor.AI doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by Receptor.AI. Ask for audit reports before you buy.

  • Software security
  • Data networking security
  • Information storage security
  • Commercially acceptable means for personal data protection

Reviews

No reviews yet

Reviews come from people who use PharmaSphere at work. Share how your team uses it to help other buyers decide.

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim PharmaSphere